Abstract
Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Current HIV Research
Title: Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression
Volume: 8 Issue: 6
Author(s): Carmen Torres, Manuel Sanchez-de-la-Torre, Carelia Garcia-Moruja, Antonio Jose Carrero, Maria del Monte Trujillo, Joan Fibla and Antonio Caruz
Affiliation:
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Abstract: Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Export Options
About this article
Cite this article as:
Torres Carmen, Sanchez-de-la-Torre Manuel, Garcia-Moruja Carelia, Carrero Jose Antonio, Trujillo del Monte Maria, Fibla Joan and Caruz Antonio, Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression, Current HIV Research 2010; 8 (6) . https://dx.doi.org/10.2174/157016210793499330
DOI https://dx.doi.org/10.2174/157016210793499330 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress as a Key Signaling Pathway in Placental Angiogenesis Changes in Preeclampsia: Updates in Pathogenesis, Novel Biomarkers and Therapeutics
Current Pharmacogenomics and Personalized Medicine The Antiplatelet Drug Target in Atherosclerotic Diseases
Cardiovascular & Hematological Disorders-Drug Targets The Endocannabinoid System May Modulate Sleep Disorders in Aging
Current Neuropharmacology The Atherosclerosis Time-Line and the Role of the Endothelium
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Potential Targets and Their Relevant Inhibitors in Anti-influenza Fields
Current Medicinal Chemistry SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets 3D-QSAR and Docking Studies on a Series of Benzothiadiazine Derivatives as Genotype 1 HCV Polymerase Inhibitors
Medicinal Chemistry Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?
Current Immunology Reviews (Discontinued) Exploiting Metabolic Differences in Glioma Therapy
Current Drug Discovery Technologies Review of In Vitro Models and Development and Initial Validation of a Novel Co-Culture Model for the Study of Osteoarthritis
Current Rheumatology Reviews Editorial [Hot Topic: Therapeutic Approaches for Vision Loss due to Choroidal Neovascularizations in Age Related Macular Degeneration (Guest Editor: Ciro Costagliola)]
Current Drug Targets Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction Pathways
Current Drug Metabolism Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Endocrine, Metabolic & Immune Disorders - Drug Targets Resveratrol Ameliorates LPS-induced Acute Lung Injury Mouse Model via Induction of Tristetraprolin
Combinatorial Chemistry & High Throughput Screening Caveolin-1 in Stroke Neuropathology and Neuroprotection: A Novel Molecular Therapeutic Target for Ischemic-Related Injury
Current Vascular Pharmacology General Molecular Biology and Architecture of Nuclear Receptors
Current Topics in Medicinal Chemistry Coumarin and Derivates as Lipid Lowering Agents
Current Topics in Medicinal Chemistry Growth Factor Therapy in Atherosclerotic Disease-Friend or Foe
Current Pharmaceutical Design Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design Electroporation: An Avenue for Transdermal Drug Delivery
Current Drug Delivery